Stocks / Pharmaceuticals
TGTXPharmaceuticals
TG Therapeutics, Inc.
$56.471d +0.9%5d +1.9%settled close · 2026-09-17
Mkt cap $4.8B (3/25)β 0.0952w $34–59Shares 159.7MInd. Pharmaceutical PreparationsNasdaq since 1995Emp. 399HQ New York, NYtgtherapeutics.com
Who’s talkingIdea Scout · free
Who’s talking about TGTX
No tracked investor commentary on TGTX yet — the corpus grows weekly.
Idea Scout tracks who’s
talking across television, podcasts, and interviews — every stance
dated to the appearance it came from.
Sign up free →
Earnings
Next report: 2 Nov 2026
Confirmed date · consensus EPS 0.37. Reactions below are the next settled session over the prior close.
The options tapeThe Brief · paid
Notable options days
Sessions in the last 120 where TGTX’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 8 of 120 sessions qualified.
The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
| Date | Close | RVOL | Δ$ flow ($M) | Call % | LEAPS % | +20 sess. |
|---|---|---|---|---|---|---|
| 2026-09-16 | ||||||
| 2026-08-21 | ||||||
| 2026-08-20 | ||||||
| 2026-08-03 | ||||||
| 2026-07-07 | ||||||
| 2026-06-17 | ||||||
| 2026-06-12 | ||||||
| 2026-06-10 |
+20 sess. = raw price change over the following 20
sessions — not market-adjusted; the tape tells you where to look,
not what happens next.
Today’s tape on
TGTX is in this morning’s Brief.
Get The Brief — $20/mo →